Clinical Trials for Chiome Bioscience

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Chiome Bioscience

Clinical Trials (2)

NCT07016997
A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors.
PHASE1Recruiting
70 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT06636435
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
PHASE1Recruiting
66 participants
Started: Jun 1, 2020 · Completed: Jun 30, 2026
4 conditions1 sponsor5 locations